Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
MD 
Mednax Inc (MD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/13/2025: MD (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
8 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $22.67
1 Year Target Price $22.67
| 3 | Strong Buy |
| 0 | Buy |
| 5 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 43.32% | Avg. Invested days 41 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 11/13/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.99B USD | Price to earnings Ratio 11.87 | 1Y Target Price 22.67 |
Price to earnings Ratio 11.87 | 1Y Target Price 22.67 | ||
Volume (30-day avg) 8 | Beta 0.81 | 52 Weeks Range 11.84 - 23.23 | Updated Date 11/14/2025 |
52 Weeks Range 11.84 - 23.23 | Updated Date 11/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.95 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-10-30 | When Before Market | Estimate 0.4379 | Actual 0.67 |
Profitability
Profit Margin 8.44% | Operating Margin (TTM) 15.02% |
Management Effectiveness
Return on Assets (TTM) 6.86% | Return on Equity (TTM) 19.98% |
Valuation
Trailing PE 11.87 | Forward PE 9.47 | Enterprise Value 2122571245 | Price to Sales(TTM) 1.03 |
Enterprise Value 2122571245 | Price to Sales(TTM) 1.03 | ||
Enterprise Value to Revenue 1.1 | Enterprise Value to EBITDA 8.03 | Shares Outstanding 85877386 | Shares Floating 83023631 |
Shares Outstanding 85877386 | Shares Floating 83023631 | ||
Percent Insiders 2.14 | Percent Institutions 101.54 |
Upturn AI SWOT
Mednax Inc
Company Overview
History and Background
Mednax, Inc. (formerly Pediatrix Medical Group) was founded in 1979. It initially focused on neonatology services and has expanded over the years to include other pediatric subspecialties and maternal-fetal medicine. It grew through acquisitions and organic growth.
Core Business Areas
- Pediatrics and Neonatology: Provides physician services in neonatal intensive care units (NICUs), pediatric intensive care units (PICUs), and other pediatric subspecialties. Also includes hospital management and clinical support services.
- Obstetrics and Maternal-Fetal Medicine: Offers physician services and management services related to obstetrics and maternal-fetal medicine. Includes high-risk pregnancy care and ultrasound services.
Leadership and Structure
The leadership team consists of the CEO, CFO, and other senior executives. The organizational structure includes regional divisions and corporate support functions.
Top Products and Market Share
Key Offerings
- Neonatal Intensive Care Services: Physician and management services in NICUs. Market share is difficult to pinpoint precisely, but Mednax is a leading provider in this area. Competitors include regional and local hospital systems, as well as other physician practice management companies. Revenue data specific to NICU services is not publicly available without breaking out total revenue.
- Maternal-Fetal Medicine Services: Provides specialized care for high-risk pregnancies. Market share data is fragmented, but Mednax holds a significant position. Competitors include large academic medical centers and other specialized OB/GYN practices. Revenue data specific to maternal-fetal medicine services is not publicly available without breaking out total revenue.
Market Dynamics
Industry Overview
The healthcare industry is experiencing increasing demand for specialized medical services, particularly in neonatology and maternal-fetal medicine. There is also a trend toward consolidation and greater emphasis on value-based care.
Positioning
Mednax is positioned as a leading national provider of specialized medical services for mothers and babies. Its competitive advantages include its scale, expertise, and established relationships with hospitals.
Total Addressable Market (TAM)
The total addressable market for maternal and neonatal services is estimated to be in the tens of billions of dollars annually in the US. Mednax is well-positioned to capture a portion of this market due to its national presence and specialized expertise. It is hard to determine the precise TAM value.
Upturn SWOT Analysis
Strengths
- National Presence
- Established Hospital Relationships
- Specialized Expertise
- Economies of Scale
Weaknesses
- High Debt Levels
- Exposure to Reimbursement Changes
- Dependence on Acquisitions
- Integration Risks
Opportunities
- Expanding Service Offerings
- Geographic Expansion
- Strategic Partnerships
- Increasing Demand for Specialized Care
Threats
- Changes in Healthcare Regulations
- Increased Competition
- Economic Downturns
- Physician Shortages
Competitors and Market Share
Key Competitors
- USPH
- AMN
- TeamHealth
Competitive Landscape
Mednax competes with other physician practice management companies, hospital systems, and academic medical centers. Its advantages include its national scale and specialized expertise. Disadvantages include high debt.
Major Acquisitions
OB Hospitalist Group
- Year: 2016
- Acquisition Price (USD millions): 230
- Strategic Rationale: Expanded Mednax's OB hospitalist services.
Growth Trajectory and Initiatives
Historical Growth: Mednax has grown historically through acquisitions and organic growth.
Future Projections: Future growth projections are based on analyst estimates and are subject to change. They often reflect expectations for revenue growth driven by increased demand for services.
Recent Initiatives: Recent strategic initiatives include focusing on core business areas and improving operational efficiency.
Summary
Mednax is a leading provider of specialized maternal and neonatal medical services with a national presence. While its scale and expertise are strengths, high debt and regulatory risks pose challenges. Focusing on core areas and strategic partnerships may improve its growth trajectory.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market share data is based on estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Mednax Inc
Exchange NYSE | Headquaters Sunrise, FL, United States | ||
IPO Launch date 1995-09-19 | CEO & Executive Chairman Mr. Mark S. Ordan | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 4120 | Website https://www.pediatrix.com |
Full time employees 4120 | Website https://www.pediatrix.com | ||
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal medicine nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and other newborn and pediatric care, as well as newborn hearing screening, and support services in hospitals, pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.